Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726041 | SCV000341416 | uncertain significance | not provided | 2016-06-07 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000311142 | SCV000711120 | likely benign | not specified | 2016-08-02 | criteria provided, single submitter | clinical testing | p.Pro522Pro in exon 14 of MYH9: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.1% (12/10304) of A frican chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadi nstitute.org; dbSNP rs145517108). |
Gene |
RCV000726041 | SCV001816915 | likely benign | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000726041 | SCV002359222 | benign | not provided | 2023-11-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535390 | SCV004756325 | likely benign | MYH9-related disorder | 2019-03-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |